RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
FRONTIERS IN IMMUNOLOGY
Collezione ASL Città di Torino

Items : 11

Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation. in Frontiers in immunology / Front Immunol. 2024 Mar 14;15:1351446. doi: 10.3389/fimmu.2024.1351446. eCollection 2024.

2024
ASL Città di Torino

Sciascia S; Rodríguez-Carrio J; Roccatello D; Suárez A; Foddai SG; Menegatti E; Radin M; Barinotti A; Cecchi I;

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2024 Sep 10;15:1460317. doi: 10.3389/fimmu.2024.1460317. eCollection 2024.

2024
ASL Città di Torino

Roccatello D; Sciascia S; Ruggenenti P; Gastoldi S; Mataj B; Carrara C;

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy. in Frontiers in immunology / Front Immunol. 2022 Mar 24;13:777134. doi: 10.3389/fimmu.2022.777134. eCollection 2022.

2022
ASL Città di Torino
AOU Città della Salute di Torino

Rossi D; De Simone E; Naretto C; Barreca A; Sammartino A; Roccatello D; Sciascia S; Murgia S; Quattrocchio G; Fenoglio R; Ferro M;

Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease. in Frontiers in immunology / Front Immunol. 2022 Jul 6;13:962088. doi: 10.3389/fimmu.2022.962088. eCollection 2022.

2022
ASL Città di Torino

Karim MY; Parodis I; Sciascia S;

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up. in Frontiers in immunology / Front Immunol. 2022 Feb 28;13:818325. doi: 10.3389/fimmu.2022.818325. eCollection 2022.

2022
ASL Città di Torino

Clerico M; Horakova D; Annovazzi POL; Adamec I; Habek M; Vladic A; Cocco E; Novelli F; Taverna D; Maglione A; Bardina V; De Mercanti SF; Rolla S;

Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d. in Frontiers in immunology / Front Immunol. 2022 Aug 10;13:949919. doi: 10.3389/fimmu.2022.949919. eCollection 2022.

2022
ASL Città di Torino

Alexander RV; Kammesheidt A; O'Malley T; Bloch R; Sciascia S;

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2022 Sep 12;13:957201. doi: 10.3389/fimmu.2022.957201. eCollection 2022.

2022
ASL Città di Torino

Serrano A; Pleguezuelo D; Serrano M; Shoenfeld Y; Benucci M; Cecchi I; Radin M; Roccatello D; Saponjski J; Regola F; Stanisavljevic N; Milanovic M; Manfredi M; Garcinuño S; Kostyra-Grabczak K; Infantino M; Sciascia S; Ma?li?ska M; Tincani A; Djokovic A; Andreoli L; Naranjo L; Stojanovich L;

Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups. in Frontiers in immunology / Front Immunol. 2021 Mar 10;12:633167. doi: 10.3389/fimmu.2021.633167. eCollection 2021.

2021
ASL Città di Torino

Confalonieri P; Mantegazza R; Michelis D; Laroni A; Peluso D; Zecca C; Brambilla L; Studer V; Donninelli G; Volpe E;

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. in Frontiers in immunology / Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.

2021
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bacco B; Norbiato C; Bertero MT; Carignola R; Cosseddu D; Montaruli B; Bazzan M; Radin M; Sciascia S; Gallo Cassarino S; Roccatello D;

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.

2021
ASL Città di Torino

Roccatello D; Sciascia S; Baldovino S; Menegatti E; Rossi D; Radin M; Arbrile M;

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. in Frontiers in immunology / Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.

2019
ASL Città di Torino
AOU Città della Salute di Torino
AOU Novara

Mahler M; Vaccarino A; Ferro M; Baldovino S; Muccini E; Pergolini P; Mengozzi G; Montaruli B; Rolla R; Scotta A; Rubini E; Radin M; Cecchi I; Sciascia S; Menegatti E; Roccatello D;